Manipulating the NKG2D Receptor-Ligand Axis Using CRISPR: Novel Technologies for Improved Host Immunity

Area of Science:

• Immunology
• Molecular Biology
• Gene Therapy

Background:

• The NKG2D receptor-ligand axis is crucial for immune surveillance against cellular stress, viral infections, and cancer.
• Viruses and tumors often evade NKG2D recognition through complex regulatory mechanisms.
• Current NKG2D-targeting therapies lack specificity, limiting their therapeutic potential.

Purpose of the Study:

• To provide an overview of the human NKG2D receptor-ligand axis.
• To discuss the regulation and dysregulation of NKG2D ligands (NKG2D-L) in viral infection and oncogenesis.
• To explore the potential of CRISPR-based technologies for enhancing NKG2D-mediated immunity.

Main Methods:

• Literature review of NKG2D receptor-ligand interactions.
• Analysis of regulatory mechanisms of NKG2D-L during disease.
• Exploration of CRISPR-Cas systems for gene editing and regulation.

Main Results:

• NKG2D-L are regulated at transcriptional, post-transcriptional, and post-translational levels.
• Dysregulation of NKG2D-L facilitates immune evasion by viruses and tumors.
• CRISPR technology presents opportunities for precise manipulation of NKG2D-L.

Conclusions:

• Overcoming NKG2D-mediated immune evasion is a promising therapeutic strategy.
• CRISPR-based gene editing offers a novel approach to enhance NKG2D-mediated immunity.
• Targeting the NKG2D axis with CRISPR may lead to advanced antiviral and cancer immunotherapies.